Formoterol Export Market Intelligence: India's 153 Suppliers Shipping to 81 Countries — TransData Nexus 2026

Q: Who are the top formoterol exporters from India?

The top formoterol exporters from India are: 1. CIPLA LIMITED — $25.3M (44.1% market share); 2. MANKIND PHARMA LIMITED — $19.3M (33.6% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $6.1M (10.7% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LTD — $1.9M (3.2% market share); 5. MEDISPRAY LABORATORIES PRIVATE LIMITED — $1.2M (2.0% market share). Together they account for 93.7% of India's total formoterol export value.

Q: What is the total export value of formoterol from India?

The total export value of formoterol from India is $57.4M USD, recorded across 4,917 shipment transactions from 153 active exporters to 81 destination countries. The average shipment value is $11.7K.

Q: Which countries import formoterol from India?

India exports formoterol to 81 countries worldwide. The top importing countries are: UNITED STATES (67.3% share, $38.7M), SRI LANKA (8.3% share, $4.8M), ALGERIA (5.6% share, $3.2M), BELGIUM (4.7% share, $2.7M), DOMINICAN REPUBLIC (3.1% share, $1.8M). These five markets account for 89.0% of total export value.

Q: What is the HS code for formoterol exports from India?

The primary HS code for formoterol exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of formoterol exports from India?

The average unit price for formoterol exports from India is $8.55 USD per unit, with prices ranging from $0.01 to $1742.05 depending on formulation, packaging, and order volume. The total market is valued at $57.4M across 4,917 shipments.

Q: Which ports handle formoterol exports from India?

The primary ports for formoterol exports from India are SAHAR AIR (18.3% of shipments), DELHI AIR (16.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (15.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (13.4% of shipments), NHAVA SHEVA SEA (INNSA1) (6.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of formoterol?

India is one of the world's leading exporters of formoterol due to its large base of 153 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports formoterol to 81 countries, demonstrating 42% global market coverage.

Q: What certifications do Indian formoterol exporters need?

Indian formoterol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import formoterol from India?

There are 320 registered buyers importing formoterol from India, spread across 81 countries. The repeat buyer rate is 70.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top formoterol supplier from India?

CIPLA LIMITED is the leading formoterol exporter from India with a market share of 44.1% and total export value of $25.3M across 572 shipments. The top 5 suppliers together control 93.7% of total export value.

Suresh Sormare

Formoterol

India Pharmaceutical Trade Intelligence

$57.4M153 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES67.3%India → SRI LANKA8.3%

#1 Supplier: CIPLA LIMITED #1 Buyer: LIFESTAR PHARMA

Formoterol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Formoterol to the World

Between 2022 and 2026, India exported $57.4M worth of formoterol across 4,917 verified shipments to 81 countries — covering 42% of world markets in the Respiratory & OTC segment. The largest destination is UNITED STATES (67.3%). CIPLA LIMITED leads with a 44.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Formoterol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Formoterol export data snapshot — $57.4M · 153 exporters · 81 countriesTransData Nexus · Indian Customs Data

Top Formoterol Exporters from India

153 active exporters · Ranked by export value

View all 153 →

Top Formoterol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$25.3M	572	25	44.1%
2	MANKIND PHARMA LIMITED

Top Countries Importing Formoterol from India

81 destination markets · Ranked by import value

All 81 countries →

Top Countries Importing Formoterol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$38.7M	67.3%
2	SRI LANKA	$4.8M	8.3%
3	ALGERIA	$3.2M	5.6%
4	BELGIUM	$2.7M	4.7%
5	DOMINICAN REPUBLIC	$1.8M	3.1%
6	YEMEN	$740.3K	1.3%
7	MAURITIUS	$725.9K	1.3%
8	KENYA	$665.9K	1.2%
9	UNITED ARAB EMIRATES	$639.5K	1.1%
10	FINLAND	$538.8K	0.9%

UNITED STATES is India's largest formoterol export destination, absorbing 67.3% of total exports worth $38.7M. The top 5 importing countries — UNITED STATES, SRI LANKA, ALGERIA, BELGIUM, DOMINICAN REPUBLIC — together account for 89.0% of India's total formoterol export value. The remaining 76 destination countries collectively receive the other 11.0%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Formoterol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Formoterol is approved for use in various inhalation products for asthma and COPD treatment. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Formoterol-containing products, indicating a competitive generic market. Notably, the high volume of Formoterol exports from India to the U.S. underscores the importance of Indian manufacturers in supplying the American market. However, Indian exporters must remain vigilant regarding FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and potential import alerts that could affect market access.

2EU & UK Regulatory Framework

In the European Union, Formoterol is incorporated into combination inhalers for asthma and COPD management. The European Medicines Agency (EMA) has granted marketing authorizations for several Formoterol-containing products. For instance, Bevespi Aerosphere, combining Formoterol with glycopyrronium bromide, received EU-wide approval on December 18, 2018. Additionally, Riltrava Aerosphere, a triple combination inhaler including Formoterol, was authorized on January 6, 2022. Manufacturers exporting to the EU and UK must adhere to stringent Good Manufacturing Practice (GMP) standards and obtain appropriate marketing authorizations from the EMA or the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

3WHO Essential Medicines & Global Standards

Formoterol is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its critical role in treating respiratory conditions. This inclusion underscores the global recognition of Formoterol's therapeutic importance. Furthermore, Formoterol formulations are standardized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different markets.

4India Regulatory Classification

In India, Formoterol is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, Formoterol is not listed under the Drugs (Prices Control) Order (DPCO), allowing manufacturers to set prices based on market dynamics. For exports, Indian pharmaceutical companies must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The primary patents for Formoterol have expired, leading to increased generic competition globally. This patent expiration has enabled multiple manufacturers to produce and export Formoterol-containing products, contributing to the substantial export figures from India. The competitive landscape necessitates that Indian exporters maintain high-quality standards and regulatory compliance to sustain and expand their market share.

6Recent Industry Developments

In the past 12 months, several developments have impacted the Formoterol market:

1. API Price Fluctuations (June 2025): The Department of Pharmaceuticals reported a 5% increase in the price of Formoterol Active Pharmaceutical Ingredient (API) due to supply chain disruptions.

2. New Generic Approvals (September 2025): The FDA approved two new generic versions of Formoterol inhalers, enhancing market competition and potentially affecting export dynamics.

3. Policy Changes in Export Regulations (January 2026): The DGFT implemented revised guidelines for pharmaceutical exports, emphasizing stricter quality control measures to align with international standards.

These developments underscore the dynamic nature of the pharmaceutical industry and the need for exporters to stay informed and adaptable to maintain a competitive edge.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Formoterol

Retail & reference prices across 9 markets vs. India FOB export price of $8.55/unit

Global Price Benchmark for Formoterol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	Pricing data sourced from the FDA's National Drug Code Directory.
United Kingdom	$0.55	GBP	According to the NHS Drug Tariff, Formoterol is listed with this average price.
Germany	$0.50	EUR	Pricing information obtained from the German Federal Institute for Drugs and Medical Devices (BfArM).
Australia	$0.45	AUD

Supply Chain Risk Assessment — Formoterol

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Formoterol, heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency poses significant risks, as any disruption in Chinese supply chains—due to geopolitical tensions, trade restrictions, or environmental regulations—can directly impact India's ability to manufacture Active Pharmaceutical Ingredients (APIs) like Formoterol.

Recent analyses have highlighted that 41% of KSMs used in U.S.-approved APIs are solely sourced from China, underscoring the global reliance on Chinese manufacturing for critical pharmaceutical components. This concentration amplifies the vulnerability of the supply chain, as any interruption in Chinese production or export activities can lead to cascading effects on global pharmaceutical manufacturing, including India's Formoterol production.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in India's Formoterol exports, with the top five exporters accounting for 93.7% of the market. CIPLA LIMITED alone holds a 44.1% share, exporting $25.3 million worth of Formoterol. This concentration presents a significant single-source risk; any operational, financial, or regulatory issues affecting these key suppliers could disrupt the entire supply chain.

Access Complete Formoterol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,917 transactions across 81 markets.

Request Demo View Pricing

Frequently Asked Questions — Formoterol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top formoterol exporters from India?

The leading formoterol exporters from India are CIPLA LIMITED, MANKIND PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 10 others. CIPLA LIMITED leads with 44.1% market share ($25.3M). The top 5 suppliers together control 93.7% of total export value.

What is the total export value of formoterol from India?

The total export value of formoterol from India is $57.4M, recorded across 4,917 shipments from 153 active exporters to 81 countries. The average shipment value is $11.7K.

Which countries import formoterol from India?

India exports formoterol to 81 countries. The top importing countries are UNITED STATES (67.3%), SRI LANKA (8.3%), ALGERIA (5.6%), BELGIUM (4.7%), DOMINICAN REPUBLIC (3.1%), which together account for 89.0% of total export value.

What is the HS code for formoterol exports from India?

The primary HS code for formoterol exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Formoterol

Formoterol

How India Exports Formoterol to the World

Top Formoterol Exporters from India

Top Countries Importing Formoterol from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Formoterol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Formoterol

Supply Chain Risk Assessment — Formoterol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Formoterol Trade Intelligence

Frequently Asked Questions — Formoterol Exports from India

Who are the top formoterol exporters from India?

What is the total export value of formoterol from India?

Which countries import formoterol from India?

What is the HS code for formoterol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of formoterol exports from India?

Which ports handle formoterol exports from India?

Why is India a leading exporter of formoterol?

What certifications do Indian formoterol exporters need?

How many buyers import formoterol from India?

What is the market share of the top formoterol exporter from India?

Analysis Methodology